Current approach to nutritional support in patients with enterocutaneous fistulas
- Authors: Struchkov V.Y.1, Sharapov I.E.1, Mamoshin A.V.1, Burmistrov A.I.1, Markov P.V.1
-
Affiliations:
- A.V. Vishnevsky National Medical Research Center of Surgery
- Issue: Vol 18, No 4 (2025)
- Pages: 291-303
- Section: Review of literature
- URL: https://vestnik-surgery.com/journal/article/view/1903
- DOI: https://doi.org/10.18499/2070-478X-2025-18-4-291-303
- ID: 1903
Cite item
Abstract
Enterocutaneous fistulas (ECFs) are a severe and potentially life-threatening complication that occurs primarily after abdominal surgery or inflammatory diseases of the gastrointestinal tract, such as Crohn's disease, diverticulitis and complicated forms of ulcerative colitis. ECF is accompanied by pronounced disorders of the water-electrolyte and protein-energy balance, the development of infectious complications, sepsis, as well as severe nutritional insufficiency. The latter is one of the key factors determining the prognosis in this category of patients, significantly affecting the outcome of treatment, the duration of hospitalization, terms of the fistula healing and the mortality rate.
This review examines in detail modern approaches to nutritional support for patients with ECF at various stages of treatment. The article highlights the diagnosis options for nutritional deficiency, including clinical and laboratory parameters, scales for assessing nutritional status and instrumental control options. Special attention is paid to the indications for parenteral, enteral and combined nutrition, the choice of route and composition of nutritional mixtures, as well as the potential use of special substrates (glutamine, omega-3 fatty acids, etc.) to modulate the metabolic response and reduce inflammation.
The data from leading clinical studies on the effectiveness of various nutritional support strategies in patients with enterocutaneous fistulas, including those in specialized centers, are analyzed. The review provides an overview of current recommendations from international expert communities, including ESPEN, ASPEN, the experience of Chinese colleagues and Russian experts. The need for an individualized approach to the choice of nutritional tactics is emphasized, taking into account the localization, the volume of intestinal discharge losses, the general condition of a patient and the phase of the disease.
Full Text
About the authors
Vladimir Y. Struchkov
A.V. Vishnevsky National Medical Research Center of Surgery
Author for correspondence.
Email: doc.struchkov@gmail.com
ORCID iD: 0000-0003-1555-1596
SPIN-code: 4996-7802
Ph.D., surgeon, oncologist of the Department of Abdominal Surgery
Russian Federation, MoscowIlya E. Sharapov
A.V. Vishnevsky National Medical Research Center of Surgery
Email: passenger99@mail.ru
ORCID iD: 0009-0001-8695-0626
Specialist of the accreditation and simulation center
Russian Federation, MoscowAndrian V. Mamoshin
A.V. Vishnevsky National Medical Research Center of Surgery
Email: dr.mamoshin@mail.ru
ORCID iD: 0000-0003-1787-5156
SPIN-code: 2553-1200
M.D., Senior Researcher at the Department of Abdominal Surgery
Russian Federation, MoscowAlexander I. Burmistrov
A.V. Vishnevsky National Medical Research Center of Surgery
Email: aibur3619@gmail.com
ORCID iD: 0000-0001-8853-3394
SPIN-code: 2674-0484
Surgeon of the Department of Abdominal Surgery
Russian Federation, MoscowPavel V. Markov
A.V. Vishnevsky National Medical Research Center of Surgery
Email: markov@ixv.ru
ORCID iD: 0000-0002-9074-5676
SPIN-code: 6808-9492
MD, Head of the Department of Abdominal Surgery
Russian Federation, MoscowReferences
- Ghimire P. Management of Enterocutaneous Fistula: A Review. JNMA J Nepal Med Assoc. 2022; 60: 245: 93-100. doi: 10.31729/jnma.5780.
- Velichko AV. Enteral nutrition in the treatment of patients with high unformed intestinal fistulas. Problemy zdorov'ya i ehkologii. 2005; 2: 4: 93–97. (in Russ.)
- Makhdoom ZA, Komar MJ, Still CD. Nutrition and enterocutaneous fistulas. J Clin Gastroenterol. 2000; 31: 3: 195-204. doi: 10.1097/00004836-200010000-00003.
- Levchik EYu. Sovershenstvovanie metodov operativnogo lecheniya naruzhnykh kishechnykh svishchei. Avtoref. dis. dok. med. nauk. Ekaterinburg. UGMA. 2004; 3. (in Russ.)
- Struchkov VYu, Berelavichus SV, Akhtanin EA, Gorin DS, Dvukhzhilov MV, Goev AA, Burmistrov AI, Markov PV, Kriger AG. Two-Stage Treatment of Enterocutaneous Fistulas. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2023;33(4):58-69. (in Russ.). doi: 10.22416/1382-4376-2023-33-4-58-69.
- Hatchimonji JS, Passman J, Kaufman EJ, et al. Enterocutaneous fistula after emergency general surgery: Mortality, readmission, and financial burden. J Trauma Acute Care Surg. 2020; 89: 1: 167-172. doi: 10.1097/TA.0000000000002673.
- Levy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM, Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg. 1989; 76: 7: 676-679. doi: 10.1002/bjs.1800760708.
- Li J, Ren J, Zhu W, Yin L, Han J. Management of enterocutaneous fistulas: 30-year clinical experience. Chin Med J (Engl). 2003; 116: 2: 171-175. doi: 10.1117/12.538864.
- Manukovskii VA, Demko AE, Usenov KK, Batyrshin IM, Fomin DV, Luft VM, Pichugina GA, Kelbetova BR, Ostroumova JS. Ten Years of Experience in the Treatment of Enteroatmospheric Fistulas at the Saint Petersburg I.I. Dzhanelidze. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I.I. Mechnikova. 2025; 17: 1: 51-62. (in Russ.). doi: 10.17816/mechnikov636058.
- Grizaenko AI, Ishtukov RR. Improvement of methods of treatment of intestinal fistula. Creative surgery and oncology. 2013; 1-2: 57-60. (in Russ.). doi: 10.24060/2076-3093-2013-0-1-2-57-60.
- Lloyd DA, Gabe SM, Windsor AC. Nutrition and management of enterocutaneous fistula. Br J Surg. 2006; 93: 9: 1045-1055. doi: 10.1002/bjs.5396.
- Martinez JL, Luque-de-León E, Ballinas-Oseguera G, Mendez JD, Juárez-Oropeza MA, Román-Ramos R. Factors predictive of recurrence and mortality after surgical repair of enterocutaneous fistula. J Gastrointest Surg. 2012; 16: 1: 156-164. doi: 10.1007/s11605-011-1703-7.
- McClave SA, Omer E. Clinical nutrition for the gastroenterologist: bedside strategies for feeding the hospitalized patient. Curr Opin Gastroenterol. 2020; 36: 2: 122-128. doi: 10.1097/MOG.0000000000000617.
- Demko AE, Batyrshin IM, Shlyapnikov SA, Ostroumova YuS, Sklizkov DS, Fomin DV, Pichugina GA. Staged approach in the treatment of patients with enterocutaneous fistulae. Khirurgiya. Zhurnal im. N.I. Pirogova. 2020; 11: 66 73. (in Russ.). doi: 10.17116/hirurgia202011166.
- Tang QQ, Hong ZW, Ren HJ, Wu L, Wang GF, Gu GS, Chen J, Zheng T, Wu XW, Ren JA, Li JS. Nutritional Management of Patients With Enterocutaneous Fistulas: Practice and Progression. Front Nutr. 2020; 7: 564379. doi: 10.3389/fnut.2020.564379.
- Kumpf VJ, de Aguilar-Nascimento JE, Diaz-Pizarro Graf JI. ASPEN-FELANPE Clinical Guidelines. JPEN J Parenter Enteral Nutr. 2017; 41: 1: 104-112. doi: 10.1177/0148607116680792.
- Nathania M, Andayani DE. Medical Nutrition Therapy In Enterocutaneous Fistula: A Step-By-Step Approach. World Nutrition Journal. 2021; 1: 5: 6–14. doi: 10.25220/WNJ.V05.i1.0002.
- Luft VM, Demko AE, Kelbetova BR, Batyrshin IM, Fomin DV, Lapitskiy AV, Pichugina GA, Sergeeva AM, Usenov KK. Problems of Nutritional and Metabolic Therapy of Patients with Intestinal Fistulas. Zhurnal im. N.V. Sklifosovskogo «Neotlozhnaya meditsinskaya pomoshch'». 2025; 14: 1: 155-165. (in Russ.) doi: 10.23934/2223-9022-2025-14-1-155-165.
- Polk TM, Schwab CW. Metabolic and nutritional support of the enterocutaneous fistula patient: a three-phase approach. World J Surg. 2012; 36: 3: 524-533. doi: 10.1007/s00268-011-1315-0.
- Chandankhede SR, Kulkarni AP. Acute Intestinal Failure. Indian J Crit Care Med. 2020; 24: 4: 168-174. doi: 10.5005/jp-journals-10071-23618.
- Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015; 34: 2: 171-180. doi: 10.1016/j.clnu.2014.08.017.
- Elia M. The «MUST» report. Nutritional screening for adults: a multidisciplinary responsibility. Development and use of the «Malnutrition Universal Screening Tool» (MUST) for adults. The British journal of nutrition. 2003; 1–127.
- Stratton RJ, Hackston A, Longmore D, Dixon R, Price S, Stroud M, King C, Elia M. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the 'malnutrition universal screening tool' ('MUST') for adults. The British journal of nutrition. 2003; №92(5); 799–808. https://doi.org/10.1079/bjn20041258 doi: 10.1016/S0261-5614(03)00098-0.
- Wischmeyer PE, Carli F, Evans DC, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Nutrition Screening and Therapy Within a Surgical Enhanced Recovery Pathway. Anesth Analg. 2018; 126: 6: 1883-1895. doi: 10.1213/ANE.0000000000002743.
- Lu CY, Wu DC, Wu IC. Serum albumin level in the management of postoperative enteric fistula for gastrointestinal cancer patients. J Invest Surg. 2008; 21: 1: 25-32. doi: 10.1080/08941930701833959.
- Kuvshinoff BW, Brodish RJ, McFadden DW, Fischer JE. Serum transferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal cutaneous fistulas. Ann Surg. 1993; 217: 6: 615-623. doi: 10.1097/00000658-199306000-00003.
- Mawdsley JE, Hollington P, Bassett P, Windsor AJ, Forbes A, Gabe SM. An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas. Aliment Pharmacol Ther. 2008; 28: 9: 1111-1121. doi: 10.1111/j.1365-2036.2008.03819.x.
- Shenkin A. Serum prealbumin: Is it a marker of nutritional status or of risk of malnutrition? Clin Chem. 2006; 52: 12: 2177-2179. doi: 10.1373/clinchem.2006.077412.
- Guglielmi G, Ponti F, Agostini M, Amadori M, Battista G, Bazzocchi A. The role of DXA in sarcopenia. Aging Clin Exp Res. 2016; 28: 6: 1047-1060. doi: 10.1007/s40520-016-0589-3.
- Lee JH, Kim HJ, Han S, Park SJ, Sim M, Lee KH. Reliability and Agreement Assessment of Sarcopenia Diagnosis through Comparison of Bioelectrical Impedance Analysis and Dual-Energy X-ray Absorptiometry. Diagnostics (Basel). 2024; 14: 9: 899. doi: 10.3390/diagnostics14090899.
- Rahbour G, Gabe SM, Ullah MR. Seven-year experience of enterocutaneous fistula with univariate and multivariate analysis of factors associated with healing: development of a validated scoring system. Colorectal Dis. 2013; 15: 9: 1162-1170. doi: 10.1111/codi.12363.
- Genton L, Cani PD, Schrenzel J. Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting. Clin Nutr. 2015; 34: 3: 341-349. doi: 10.1016/j.clnu.2014.10.003.
- Reboldi A, Cyster JG. Peyer's patches: organizing B-cell responses at the intestinal frontier. Immunol Rev. 2016; 271: 1: 230-245. doi: 10.1111/imr.12400.
- Ortiz LA, Zhang B, McCarthy MW, et al. Treatment of Enterocutaneous Fistulas, Then and Now. Nutr Clin Pract. 2017; 32: 4: 508-515. doi: 10.1177/0884533617701402.
- Gonzalez-Pinto I, González EM. Optimising the treatment of upper gastrointestinal fistulae. Gut. 2001; 49: 4: 22-31. doi: 10.1136/gut.49.suppl_4.iv21.
- Klek S, Forbes A, Gabe S, et al. Management of acute intestinal failure: A position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group. Clin Nutr. 2016; 35: 6: 1209-1218. doi: 10.1016/j.clnu.2016.04.009218.
- Deutsch L, Cloutier A, Lal S. Advances in chronic intestinal failure management and therapies. Curr Opin Gastroenterol. 2020; 36: 3: 223-229. doi: 10.1097/MOG.0000000000000631.
- Stanga Z, Brunner A, Leuenberger M, Grimble RF, Shenkin A, Allison SP, Lobo DN. Nutrition in clinical practice-the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur J Clin Nutr. 2008; 62: 6: 687-694. doi: 10.1038/sj.ejcn.1602854.
- Pantoja F, Fragkos KC, Patel PS. Refeeding syndrome in adults receiving total parenteral nutrition: An audit of practice at a tertiary UK centre. Clin Nutr. 2019; 38: 3: 1457-1463. doi: 10.1016/j.clnu.2018.06.967.
- Langkamp-Henken B. If the gut works, use it: but what if you can't? Nutr Clin Pract. 2003; 18: 6: 449-450. doi: 10.1177/0115426503018006449.
- Li JS. Gastrointestinal fistula. Chin J Surg. 1978; 4: 214-217.
- Heyland DK, Dhaliwal R, Day A, Jain M, Drover J. Validation of the Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients: results of a prospective observational study. Crit Care Med. 2004; 32: 11: 2260-2266. doi: 10.1097/01.ccm.0000145581.54571.32.
- Wu Y, Ren J, Wang G, Zhou B, Ding C, Gu G, Chen J, Liu S, Li J. Fistuloclysis improves liver function and nutritional status in patients with high-output upper enteric fistula. Gastroenterol Res Pract. 2014; 2014: 941514. doi: 10.1155/2014/941514.
- Bebarova L, Stasek M, Szkorupa M, Rezac T, Skalicky P, HorakovaM, Dostalova K, Lovecek M. Fistuloclysis as a method of nutritional management in a patient with high output enteroatmospheric fistula - a case report. Rozhl Chir. 2019;98(7):287-290. (In Czech). doi: 10.33699/PIS.2019.98.7.287–290.
- Levy E, Palmer DL, Frileux P, Parc R, Huguet C, Loygue J. Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the distal small bowel. A clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg. 1983; 198: 5: 596-600. doi: 10.1097/00000658-198311000-00006.
- Picot D, Layec S, Dussaulx L, Trivin F, Thibault R. Chyme reinfusion in patients with intestinal failure due to temporary double enterostomy: A 15-year prospective cohort in a referral centre. Clin Nutr. 2017; 36: 2: 593-600. doi: 10.1016/j.clnu.2016.04.020.
- King RF, Norton T, Hill GL. A double-blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust N Z J Surg. 1982; 52: 2: 121-124. doi: 10.1111/j.1445-2197.1982.tb06083.x.
- Hernandez-Aranda JC, Gallo-Chico B, Flores-Ramírez LA, Avalos-Huante R, Magos-Vazquez FJ, Ramírez-Barba EJ. Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition. Nutr Hosp. 1996; 11: 4: 226-229. (In Spanish)
- Cooper AM, Braatvedt GD, Qamar MI. Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man. Clin Sci (Lond). 1991; 81: 2: 169-175. doi: 10.1042/cs0810169.
- euser M, Popken O, Kleiman I, Post S. Detrimental effects of octreotide on intestinal microcirculation. J Surg Res. 2000; 92: 2: 186-192. doi: 10.1006/jsre.2000.5898.
Supplementary files













